WINTON GROUP Ltd Sells 14,344 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

WINTON GROUP Ltd reduced its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 79.8% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,630 shares of the company’s stock after selling 14,344 shares during the period. WINTON GROUP Ltd’s holdings in Acadia Healthcare were worth $245,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of ACHC. Vanguard Personalized Indexing Management LLC grew its stake in shares of Acadia Healthcare by 38.3% in the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 9,668 shares of the company’s stock valued at $752,000 after buying an additional 2,679 shares during the period. Coldstream Capital Management Inc. raised its holdings in shares of Acadia Healthcare by 16.8% in the 4th quarter. Coldstream Capital Management Inc. now owns 5,978 shares of the company’s stock worth $465,000 after purchasing an additional 859 shares during the period. Clearbridge Investments LLC raised its holdings in shares of Acadia Healthcare by 0.8% in the 4th quarter. Clearbridge Investments LLC now owns 198,058 shares of the company’s stock worth $15,401,000 after purchasing an additional 1,511 shares during the period. Franklin Resources Inc. raised its holdings in shares of Acadia Healthcare by 30.2% in the 4th quarter. Franklin Resources Inc. now owns 16,632 shares of the company’s stock worth $1,293,000 after purchasing an additional 3,856 shares during the period. Finally, TCW Group Inc. raised its holdings in shares of Acadia Healthcare by 25.2% in the 4th quarter. TCW Group Inc. now owns 37,148 shares of the company’s stock worth $2,889,000 after purchasing an additional 7,486 shares during the period.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $77.94 on Thursday. Acadia Healthcare Company, Inc. has a fifty-two week low of $62.04 and a fifty-two week high of $87.77. The company has a 50 day simple moving average of $72.86 and a two-hundred day simple moving average of $72.04. The company has a market capitalization of $7.23 billion, a price-to-earnings ratio of -556.71, a P/E/G ratio of 2.22 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The business had revenue of $796.00 million during the quarter, compared to the consensus estimate of $784.38 million. During the same quarter last year, the firm earned $0.92 earnings per share. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. Analysts expect that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have issued reports on ACHC. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Monday, August 19th. Barclays reduced their price target on shares of Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. Finally, Royal Bank of Canada restated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Wednesday, May 22nd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $87.44.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.